PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
11-Jun-2025 SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines SpliceBio
11-Jun-2025 Angelini Ventures Invests into €11.25 Million Seed Round for Elkedonia to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders Angelini Ventures
11-Jun-2025 Northern Gritstone invests in Manchester spinout Apini Northern Gritstone
11-Jun-2025 Rare disease biotech announces ‘hugely significant’ milestone with selection of candidate drug SynaptixBio
11-Jun-2025 ADA 2025: Novo Nordisk highlights strong portfolio data with new semaglutide and CagriSema results, redefining possibilities in obesity and diabetes care Novo Nordisk
11-Jun-2025 PARSORTIX SYSTEM ENABLES NOVEL DISCOVERIES INTO THE BIOLOGY OF CANCER PARSORTIX
11-Jun-2025 Alys Pharmaceuticals announces CTA submission for ALY-301, the first mast cell selective c-Kit inhibitor for treatment of Cold Urticaria Alys Pharmaceuticals
11-Jun-2025 Microbiotica announces the appointment of Dr Robert Tansley as Chief Medical Officer Microbiotica
11-Jun-2025 Axio BioPharma and Likarda Announce Strategic Partnership to Accelerate Biologic Drug Development and Delivery Axio BioPharma
11-Jun-2025 Advent to acquire a significant minority stake in Felix Pharmaceuticals, Ireland Felix Pharmaceuticals
10-Jun-2025 Meteor Biotech opens US office on UCLA campus to support biomedical research partners in North America Andrew Lloyd Associates
10-Jun-2025 Enalees launches Rhéa, new range of rapid molecular tests intended for ruminants Andrew Lloyd Associates
10-Jun-2025 Alfa Chemistry Expands Portfolio with High-Purity Marine and Plant-Derived Bioactive Peptides Alfa Chemistry
05-Jun-2025 Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 Development Aravax
04-Jun-2025 The UK must act to stem £11bn loss to health research ABPI
04-Jun-2025 Commit Biologics appoints leading industry experts to newly formed Scientific Advisory Board Commit Biologics
04-Jun-2025 OncoZenge Appoints LINK Medical to Execute Phase 3 Feasibility Study in Europe OncoZenge
04-Jun-2025 Spago Nanomedical continues patient recruitment in the phase I/IIa study Tumorad-01 as planned after DMC recommendation Spago Nanomedical
04-Jun-2025 Commit Biologics appoints leading industry experts to newly formed Scientific Advisory Board Commit Biologics
03-Jun-2025 Astoriom Expands Global Footprint for Sample Stability Storage Services Astoriom